This observation contradicts previous studies showing that PTEN loss correlates with shorter recurrence-free survival in breast cancer and worse overall survival in head and neck squamous-cell carcinoma patients treated with chemotherapy [20,21]. This evidence concerns the gene PTEN and breast carcinoma.